SEC Form 6-K filed by Sol-Gel Technologies Ltd.
$SLGL
Biotechnology: Pharmaceutical Preparations
Health Care
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the month of November 2024
Commission File Number 001-38367
SOL-GEL TECHNOLOGIES LTD.
(Translation of registrant’s name into English)
7 Golda Meir Street
Ness Ziona 7403650, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or
Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule
101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule
101(b)(7): ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
At the Special Meeting of Shareholders of Sol-Gel Technologies Ltd. (the "Company") held today, the following resolutions were approved
by the shareholders:
| (1) |
To approve the appointment of Mr. Moshe Arkin, the current Executive Chairman of the Board of Directors [and the Company's controlling shareholder], as the interim
Chief Executive Officer of the Company, in addition to his role as Executive Chairman, for a term not to exceed twelve months, effective January 1, 2025, subject to and in accordance with, the provisions of the Israeli Companies Law,
5759-1999, or the Companies Law; and
|
| (2) |
To approve the Company's 2024 Employees Share Incentive Plan.
|
This Form 6-K and related exhibit are hereby incorporated by reference into the Company's Registration Statements on Form S-8
(Registration Nos. 333-223915 and 333-270477) and its Registration Statement on Form F-3 (Registration No. 333-264190).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
SOL-GEL TECHNOLOGIES LTD.
|
|
|
Date: November 04, 2024
|
By:
|
/s/ Eyal Ben-Or
|
|
|
|
Eyal Ben-Or
|
|
|
|
Chief Financial Officer
|